Clinical Trial Update: Treatment of Chronic Anemia With Epoetin Alfa in Elderly [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating epoetin alfa for chronic anemia in elderly; current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Epogen (epoetin alfa)
• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Research and Education Foundation of Michael Reese Hospital | Conditions: Anemia | Phase 2 | Status: UNKNOWN